GenomeMe specializes in in-vitro companion diagnostic test development and services. Our facility is MDSAP/ISO13485:2016 accredited to meet your most challenging clinical trial requirements. With our proprietary mAb technology, we are the first and only institution globally to develop each of the 260+ clinical IHC antibodies currently used in hospital worldwide, including the most technically demanding PD-L1 Abs for different companion CDx tests. We are also leading in recombinant AAV and lentivirus, providing in vivo grade viruses for animal testing in various gene and immunotherapy programs.
Contact this Exhibitor
Text
Cancel OK
